Submissions for variant NM_000251.2(MSH2):c.2205C>T (p.Ile735=) (rs533553381)

Total submissions: 12

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000212617	SCV000170347	benign	not specified	2013-12-27	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics	RCV000126821	SCV000212951	likely benign	Hereditary cancer-predisposing syndrome	2014-09-16	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000323210	SCV000430933	uncertain significance	Lynch syndrome	2016-06-14	criteria provided, single submitter	clinical testing
Counsyl	RCV000409899	SCV000488353	likely benign	Lynch syndrome I	2016-03-08	criteria provided, single submitter	clinical testing
Invitae	RCV000590738	SCV000559194	benign	not provided	2019-03-03	criteria provided, single submitter	clinical testing
Department of Pathology and Laboratory Medicine,Sinai Health System	RCV000212617	SCV000592543	benign	not specified	2015-05-20	criteria provided, single submitter	clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano	RCV000212617	SCV000601460	benign	not specified	2017-04-18	criteria provided, single submitter	clinical testing
Color	RCV000126821	SCV000685022	benign	Hereditary cancer-predisposing syndrome	2015-06-11	criteria provided, single submitter	clinical testing
Integrated Genetics/Laboratory Corporation of America	RCV000590738	SCV000696238	benign	not provided	2016-08-15	criteria provided, single submitter	clinical testing	Variant summary: The MSH2 c.2205C>T (p.Ile735Ile) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 185/121382 control chromosomes (2 homozygotes), predominantly observed in the South Asian subpopulation at a frequency of 0.0109038 (180/16508). This frequency is about 19 times the estimated maximal expected allele frequency of a pathogenic MSH2 variant (0.0005683), suggesting this is likely a benign polymorphism found primarily in the populations of South Asian origin. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. One internal sample also carried a disease variant in BRCA1 c.3869_3870delAA, further suppporting the benign classification. Taken together, this variant is classified as benign.
PreventionGenetics,PreventionGenetics	RCV000212617	SCV000806027	benign	not specified	2017-07-06	criteria provided, single submitter	clinical testing
Mayo Clinic Genetic Testing Laboratories,Mayo Clinic	RCV000212617	SCV000691910	likely benign	not specified		no assertion criteria provided	clinical testing
True Health Diagnostics	RCV000126821	SCV000805269	likely benign	Hereditary cancer-predisposing syndrome	2018-05-09	no assertion criteria provided	clinical testing